by Mike Masnick
Thu, Nov 19th 2009 6:10pm
We've had a few posts recently about the growing scandal in the pharma and publishing worlds, whereby big pharma companies would produce fake medical journals with the stamp of approval from big publishing houses, to make it look like their drugs had a lot more scientific support than they really did. To make matters even more insane, often the pharma companies would ghostwrite articles, and then get professors to basically put their names on the works, which were designed to emphasize the benefits of certain drugs, while hiding or de-emphasizing the risks. Copycense points us to the good news that Senator Grassley is at least asking various med schools to explain why this was allowed, while probing how putting professors names on ghostwritten articles is any different than plagiarism.
If you liked this post, you may also be interested in...
- A Month Ago, Dianne Feinstein Said Cybersecurity Was Super Important... Now She Says We Should Undermine Encryption
- Should Doctors Who Put Their Names On Ghostwritten 'Journal' Articles For Big Pharma Be Sued For Fraud?
- Elsevier Reveals More Details About Its Fake Journal Division
- Elsevier Had A Whole Division Publishing Fake Medical Journals
- Big Publishers Increasingly Experimenting With Free Academic Journals